Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (141-150 of 778) with videos related to

Pageof 78
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2021
Oral antithrombotic therapy for the prevention of recurrent cerebrovascular eventsDavide Capodanno, Dominick J Angiolillo
Lancet (London, England)|August 31, 2018
Aspirin for primary prevention of cardiovascular diseaseDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|May 22, 2017
Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing DirectionsDavide Capodanno, Dominick J Angiolillo
Current Treatment Options in Cardiovascular Medicine|October 22, 2011
Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrumsDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|December 19, 2014
Bivalirudin for acute coronary syndromes: premises, promises and doubtsDavide Capodanno, Raffaele De Caterina
Circulation|December 25, 2013
Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryDavide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|March 9, 2016
Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patientsDavide Capodanno, Dominick J Angiolillo
Circulation|January 9, 2023
Long-Term P2Y<sub>12</sub> Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary InterventionDavide Capodanno, Dominick J Angiolillo
Journal of the American College of Cardiology|March 2, 2019
Pre-Treatment With Oral P2Y<sub>12</sub> Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga ContinuesDavide Capodanno, Dominick J Angiolillo
Lancet (London, England)|September 8, 2019
Dual antithrombotic therapy for atrial fibrillation and PCIDavide Capodanno, Dominick J Angiolillo
Pageof 78

Showing results (141-150 of 778) with videos related to

Sort By:
Pageof 78
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2021
Oral antithrombotic therapy for the prevention of recurrent cerebrovascular eventsDavide Capodanno, Dominick J Angiolillo
Lancet (London, England)|August 31, 2018
Aspirin for primary prevention of cardiovascular diseaseDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|May 22, 2017
Antithrombotic Therapy for Prevention of Cerebral Thromboembolic Events After Transcatheter Aortic Valve Replacement: Evolving Paradigms and Ongoing DirectionsDavide Capodanno, Dominick J Angiolillo
Current Treatment Options in Cardiovascular Medicine|October 22, 2011
Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrumsDavide Capodanno, Dominick J Angiolillo
Thrombosis and Haemostasis|December 19, 2014
Bivalirudin for acute coronary syndromes: premises, promises and doubtsDavide Capodanno, Raffaele De Caterina
Circulation|December 25, 2013
Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgeryDavide Capodanno, Dominick J Angiolillo
Expert Review of Cardiovascular Therapy|March 9, 2016
Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patientsDavide Capodanno, Dominick J Angiolillo
Circulation|January 9, 2023
Long-Term P2Y<sub>12</sub> Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary InterventionDavide Capodanno, Dominick J Angiolillo
Journal of the American College of Cardiology|March 2, 2019
Pre-Treatment With Oral P2Y<sub>12</sub> Inhibitors in Acute Coronary Syndromes Without ST-Segment Elevation: The Saga ContinuesDavide Capodanno, Dominick J Angiolillo
Lancet (London, England)|September 8, 2019
Dual antithrombotic therapy for atrial fibrillation and PCIDavide Capodanno, Dominick J Angiolillo
Pageof 78